Baidu
map

医患交流有助肾病患者理解疾病预后

2012-04-20 范振光 手牵手博客

    美国杜克大学医学院的Jane O. Schell博士在《美国肾病杂志》(Am J Kidney Dis. 2012 Apr;59(4):495-503.)发表文章指出,肾脏科医师和老年患者讨论肾脏病的病程进展有助患者更好地理解疾病预后并做好准备。       老年晚期肾脏病患者往往伴随较高残疾发病率和死亡率。研究旨在发现如果医生和患者就

    美国杜克大学医学院的Jane O. Schell博士在《美国肾病杂志》(Am J Kidney Dis. 2012 Apr;59(4):495-503.)发表文章指出,肾脏科医师和老年患者讨论肾脏病的病程进展有助患者更好地理解疾病预后并做好准备。
 
    老年晚期肾脏病患者往往伴随较高残疾发病率和死亡率。研究旨在发现如果医生和患者就肾脏病发病到肾脏替代治疗的过程和预后进行充分讨论和理解,是否能够帮助患者更好地理解疾病病程发展轨迹并做好准备。
 
肾脏疾病 医患交流
 
    研究者记录11位肾脏专科医生和29位65岁以上晚期慢性肾病或血透患者的之间就诊时的谈话录音和录音记录,对描述肾病病程发展的6个相关会谈主题进行定性分析:
(1)患者对疾病诊断感到震惊(2)患者不确定肾脏疾病会如何进展(3)患者对接受血液透析的生活缺乏准备,(4)肾脏专科医生难以对患者解释复杂的肾脏疾病(5)肾脏专科医对肾脏疾病的控制不理想,(6)肾脏专科医往往避免和患者讨论疾病未来发展。
 
    医生和患者都承认较少讨论肾脏预后。患者往往关注目前临床状态而避免谈及疾病发展未来,医生则担心相关对话会引起患者消极反应而影响会谈。
 
    结论:医生和患者都面临挑战如何更好地理解和应对肾脏疾病进展。医患之间关于疾病发展轨迹的有效会谈,可能有助提高患者对疾病预后的理解并为未来做好准备。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1739316, encodeId=7fcc1e3931656, content=<a href='/topic/show?id=908be07412a' target=_blank style='color:#2F92EE;'>#疾病预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70741, encryptionId=908be07412a, topicName=疾病预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b25634523578, createdName=ms2694732865965676, createdTime=Sat May 26 06:14:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025758, encodeId=af192025e58f3, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jun 02 05:14:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069549, encodeId=539f2069549ed, content=<a href='/topic/show?id=774c3434644' target=_blank style='color:#2F92EE;'>#医患交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34346, encryptionId=774c3434644, topicName=医患交流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 12 05:14:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1284547, encodeId=ca87128454e96, content=<a href='/topic/show?id=da9934342b5' target=_blank style='color:#2F92EE;'>#医患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34342, encryptionId=da9934342b5, topicName=医患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1739316, encodeId=7fcc1e3931656, content=<a href='/topic/show?id=908be07412a' target=_blank style='color:#2F92EE;'>#疾病预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70741, encryptionId=908be07412a, topicName=疾病预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b25634523578, createdName=ms2694732865965676, createdTime=Sat May 26 06:14:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025758, encodeId=af192025e58f3, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jun 02 05:14:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069549, encodeId=539f2069549ed, content=<a href='/topic/show?id=774c3434644' target=_blank style='color:#2F92EE;'>#医患交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34346, encryptionId=774c3434644, topicName=医患交流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 12 05:14:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1284547, encodeId=ca87128454e96, content=<a href='/topic/show?id=da9934342b5' target=_blank style='color:#2F92EE;'>#医患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34342, encryptionId=da9934342b5, topicName=医患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1739316, encodeId=7fcc1e3931656, content=<a href='/topic/show?id=908be07412a' target=_blank style='color:#2F92EE;'>#疾病预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70741, encryptionId=908be07412a, topicName=疾病预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b25634523578, createdName=ms2694732865965676, createdTime=Sat May 26 06:14:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025758, encodeId=af192025e58f3, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jun 02 05:14:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069549, encodeId=539f2069549ed, content=<a href='/topic/show?id=774c3434644' target=_blank style='color:#2F92EE;'>#医患交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34346, encryptionId=774c3434644, topicName=医患交流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 12 05:14:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1284547, encodeId=ca87128454e96, content=<a href='/topic/show?id=da9934342b5' target=_blank style='color:#2F92EE;'>#医患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34342, encryptionId=da9934342b5, topicName=医患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1739316, encodeId=7fcc1e3931656, content=<a href='/topic/show?id=908be07412a' target=_blank style='color:#2F92EE;'>#疾病预后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70741, encryptionId=908be07412a, topicName=疾病预后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b25634523578, createdName=ms2694732865965676, createdTime=Sat May 26 06:14:00 CST 2012, time=2012-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025758, encodeId=af192025e58f3, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Sat Jun 02 05:14:00 CST 2012, time=2012-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2069549, encodeId=539f2069549ed, content=<a href='/topic/show?id=774c3434644' target=_blank style='color:#2F92EE;'>#医患交流#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34346, encryptionId=774c3434644, topicName=医患交流)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Tue Jun 12 05:14:00 CST 2012, time=2012-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1284547, encodeId=ca87128454e96, content=<a href='/topic/show?id=da9934342b5' target=_blank style='color:#2F92EE;'>#医患#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34342, encryptionId=da9934342b5, topicName=医患)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c0e3195, createdName=millore, createdTime=Sun Apr 22 10:14:00 CST 2012, time=2012-04-22, status=1, ipAttribution=)]
    2012-04-22 millore

相关资讯

儿童常见肾脏疾病治疗现状调研启动

    由中华医学会儿科学分会肾脏病学组组织的“儿童常见肾脏疾病治疗现状”多中心调研项目日前启动,该调研旨在掌握我国肾病患儿治疗现状的相关数据,进一步规范儿科肾脏疾病的诊疗工作。      据中华医学会儿科学分会肾脏病学组组长、北京大学第一医院副院长丁洁教授介绍,该肾病学组在2009年-2010年期间,按照循证医学原则制定了《儿童

Baidu
map
Baidu
map
Baidu
map